Harbor Capital Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-34,930
| Closed | -$1.67M | – | 837 |
|
|
2023
Q4 | $1.67M | Buy |
34,930
+3,048
| +10% | +$146K | 0.32% | 81 |
|
|
2023
Q3 | $1.14M | Buy |
31,882
+5,910
| +23% | +$211K | 0.24% | 103 |
|
|
2023
Q2 | $1.2M | Buy |
+25,972
| New | +$1.2M | 0.24% | 105 |
|
|
2023
Q1 | – | Sell |
-2,264
| Closed | -$105K | – | 269 |
|
|
2022
Q4 | $105K | Buy |
2,264
+469
| +26% | +$21.7K | 0.1% | 85 |
|
|
2022
Q3 | $74K | Sell |
1,795
-1,123
| -38% | -$46.3K | 0.07% | 134 |
|
|
2022
Q2 | $174K | Buy |
2,918
+592
| +25% | +$35.3K | 0.13% | 87 |
|
|
2022
Q1 | $169K | Buy |
+2,326
| New | +$169K | 0.08% | 113 |
|